| Name | sp-5,6-dci-cbimps |
|---|---|
| Synonyms |
Sp-5,6-Dichloro-cBIMPS, cAMP-dendent protein kinase activator
1H-Benzimidazole, 5,6-dichloro-1-[3,5-O-[(S)-mercaptophosphinylidene]-β-D-ribofuranosyl] 5,6-DCL-CBIMPSASP-ISOMER 5,6-Dichloro-1-b-D-ribofuranosylbenzimidazole-3μ,5μ-cyclic monophosphorothioate, Sp- isomer sodium salt SP-5,6-DCI-CBIMPS 5,6-Dichloro-1-B-D-ribofuranosylbenzimidazole-3'',5''-cyclic monophosphothioa 5,6-dichloro-1-beta-d-ribofuranosylbenzimidazole-3’,5’-monophosphorothioate 5,6-dichlorobenzimidazoleriboside-3’,5’-monophosphorothioate,sp-isomer(sp5,6-dcl-cbimps) SP-5,6-DICHLORO-1-BETA-D-RIBOFURANOSYLBENZIMIDAZOLE-3',5'-MONOPHOSPHOROTHIOATE Sp 5,6-DCl-cBIMPS 5,6-Dichloro-(1-β-D-ribofuranosyl) benzimidazole 3',5'-cyclic monophosphothioate, Sp-isomer sodium salt MFCD06795834 5,6-Dichloro-(1-b-D-ribofuranosyl) benzimidazole 3',5'-cyclic monophosphothioate, Sp-isomer sodium salt |
| Description | Sp-5,6-DCl-cBIMPS is a potent and specific cAMP-dependent protein kinases (cAMP-PK) activator. Sp-5,6-DCl-cBIMPS stimulates insulin release. Sp-5,6-DCl-cBIMPS inhibits U46619-induced activation of Rho, Gq and G12/G13 in platelets[1][2][3]. |
|---|---|
| Related Catalog | |
| In Vitro | Sp-5,6-DCl-cBIMPS (0.005, 0.05, 0.5 mM; 60 min) 以剂量和时间依赖性方式刺激离体胰岛释放胰岛素[2]。 Sp-5,6-DCl-cBIMPS (0.005, 0.05, 0.5 mM; 60 min) 增加葡萄糖 (8.5 mM) 刺激的胰岛素释放[2]。 SSp-5,6-DCl-cBIMPS (100 µM; 20 min) 抑制野生型小鼠血小板中 U46619 诱导的 Rho 激活,并抑制 U46619 诱导的人血小板中 Gq 和 G12/G13 激活[3 ]。 Western Blot Analysis[3] Cell Line: Wild-type mice, Human platelets Concentration: 100 µM Incubation Time: 20 min Result: Strongly suppressed U46619-induced Rho activation in wild-type, and inhibited U46619-induced activation of both Gq and G12/G13. |
| References |
| Molecular Formula | C12H10Cl2N2NaO5PS |
|---|---|
| Molecular Weight | 419.15300 |
| Exact Mass | 417.93200 |
| PSA | 130.70000 |
| LogP | 3.32240 |
| WGK Germany | 3 |
|---|